{"id":22901,"date":"2023-01-13T00:01:00","date_gmt":"2023-01-12T16:01:00","guid":{"rendered":"https:\/\/flcube.com\/?p=22901"},"modified":"2025-01-25T00:16:43","modified_gmt":"2025-01-24T16:16:43","slug":"china-launches-eighth-round-of-national-volume-based-procurement-for-41-drugs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=22901","title":{"rendered":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs"},"content":{"rendered":"\n<p>The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round of the national volume-based procurement (VBP) program. Hospitals are required to begin providing details of the volumes required for a list of 41 drugs across 181 specifications starting from January 13. This round focuses entirely on chemical drugs, with several molecules already featured in earlier VBP rounds in differing dosage forms.<\/p>\n\n\n\n<p><strong>List of Drugs and Previous VBP Participation<\/strong><br>The list includes six molecules that have been part of previous VBP rounds:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Metronidazole injection: The tablet form was included in the 2nd round VBP, with China Grand Pharmaceutical and Healthcare Holdings Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/0512:HKG\">HKG: 0512<\/a>) and Sichuan Kelun Pharmaceutical Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/002422:SHE\">SHE: 002422<\/a>) winning spots.<\/li>\n\n\n\n<li>Mecobalamin injection: The tablet form was part of the 3rd VBP, with Eisai and Jiangxi Qingfeng Pharmaceutical Co., Ltd winning spots.<\/li>\n\n\n\n<li>Cefdinir granules: The capsule\/dispersible tablet form was included in VBP3, won by SSY Group Limited (<a href=\"https:\/\/www.google.com\/finance\/quote\/2005:HKG\">HKG: 2005<\/a>), Hansoh Pharmaceutical Group Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/3692:HKG\">HKG: 3692<\/a>), China National Pharmaceutical Group Co., Ltd (Sinopharm), and Chengdu Brilliant Pharmaceutical Co. Ltd.<\/li>\n\n\n\n<li>Voriconazole injection: The tablet form was included in VBP4, won by Sandoz, Uni-Bio Science Group Ltd, and Zhejiang Huahai Pharmaceutical Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/600521:SHA\">SHA: 600521<\/a>).<\/li>\n\n\n\n<li>Ornidazole injection: The tablet form was part of VBP7, won by Kelun Pharma, Tiscend Pharmaceutical, Huadong Medicine Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/000963:SHE\">SHE: 000963<\/a>), and Hangzhou Muyuan Biomedicine Technology Co., Ltd.<\/li>\n\n\n\n<li>Oseltamivir dry suspension: The capsule form was included in VBP7, won by Hetero, Kelun Pharma, HEC, and seven other companies.<\/li>\n<\/ul>\n\n\n\n<p><strong>Timeline for Volume Reporting<\/strong><br>Hospitals have until February 8, 2023, to file their volume requirements to the provincial healthcare security administration bureaus. The alliance procurement office is expected to receive relevant data by February 21.<\/p>\n\n\n\n<p><strong>Future Outlook<\/strong><br>The initiation of the eighth VBP round underscores the National Healthcare Security Administration&#8217;s ongoing efforts to streamline drug procurement and control costs. With a focus on chemical drugs and the inclusion of several previously featured molecules, this round aims to further optimize the availability and affordability of essential medications. The detailed timeline for volume reporting ensures a structured approach to the procurement process, benefiting both healthcare providers and patients.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[1944,683,363,2357,1134,1184,2479,1182,114,775,371,3292,747,1381,887,1185,2311,2480,3291,1627,82],"class_list":["post-22901","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-brilliant-pharma","tag-grand-pharmaceutical","tag-hansoh-pharmaceutical","tag-hec","tag-hetero-biopharma","tag-hkg-0512","tag-hkg-2005","tag-hkg-3692","tag-huadong-medicine","tag-huahai-pharmaceutical","tag-kelun-pharmaceutical","tag-muyuan-biomedicine-technology","tag-sandoz","tag-sha-600521","tag-she-000963","tag-she-002422","tag-sinopharm-group-company","tag-ssy-group","tag-tiscend-pharmaceutical","tag-uni-bio-science","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round of the national volume-based procurement (VBP) program. Hospitals are required to begin providing details of the volumes required for a list of 41 drugs across 181 specifications starting from January 13. This round focuses entirely on chemical drugs, with several molecules already featured in earlier VBP rounds in differing dosage forms.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=22901\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=22901\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-12T16:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-24T16:16:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs\",\"datePublished\":\"2023-01-12T16:01:00+00:00\",\"dateModified\":\"2025-01-24T16:16:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901\"},\"wordCount\":358,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Brilliant Pharma\",\"Grand Pharmaceutical\",\"Hansoh Pharmaceutical\",\"HEC\",\"Hetero Biopharma\",\"HKG: 0512\",\"HKG: 2005\",\"HKG: 3692\",\"Huadong Medicine\",\"Huahai Pharmaceutical\",\"Kelun Pharmaceutical\",\"Muyuan Biomedicine Technology\",\"Sandoz\",\"SHA: 600521\",\"SHE: 000963\",\"SHE: 002422\",\"Sinopharm Group Company\",\"SSY Group\",\"Tiscend Pharmaceutical\",\"Uni-Bio Science\",\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=22901#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=22901\",\"name\":\"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-01-12T16:01:00+00:00\",\"dateModified\":\"2025-01-24T16:16:43+00:00\",\"description\":\"The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round of the national volume-based procurement (VBP) program. Hospitals are required to begin providing details of the volumes required for a list of 41 drugs across 181 specifications starting from January 13. This round focuses entirely on chemical drugs, with several molecules already featured in earlier VBP rounds in differing dosage forms.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=22901\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=22901#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs - Insight, China&#039;s Pharmaceutical Industry","description":"The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round of the national volume-based procurement (VBP) program. Hospitals are required to begin providing details of the volumes required for a list of 41 drugs across 181 specifications starting from January 13. This round focuses entirely on chemical drugs, with several molecules already featured in earlier VBP rounds in differing dosage forms.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=22901","og_locale":"en_US","og_type":"article","og_title":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=22901","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-01-12T16:01:00+00:00","article_modified_time":"2025-01-24T16:16:43+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=22901#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=22901"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs","datePublished":"2023-01-12T16:01:00+00:00","dateModified":"2025-01-24T16:16:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=22901"},"wordCount":358,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Brilliant Pharma","Grand Pharmaceutical","Hansoh Pharmaceutical","HEC","Hetero Biopharma","HKG: 0512","HKG: 2005","HKG: 3692","Huadong Medicine","Huahai Pharmaceutical","Kelun Pharmaceutical","Muyuan Biomedicine Technology","Sandoz","SHA: 600521","SHE: 000963","SHE: 002422","Sinopharm Group Company","SSY Group","Tiscend Pharmaceutical","Uni-Bio Science","VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=22901#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=22901","url":"https:\/\/flcube.com\/?p=22901","name":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-01-12T16:01:00+00:00","dateModified":"2025-01-24T16:16:43+00:00","description":"The National Healthcare Security Administration has issued a notice to initiate the COVID-delayed eighth round of the national volume-based procurement (VBP) program. Hospitals are required to begin providing details of the volumes required for a list of 41 drugs across 181 specifications starting from January 13. This round focuses entirely on chemical drugs, with several molecules already featured in earlier VBP rounds in differing dosage forms.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=22901#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=22901"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=22901#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Launches Eighth Round of National Volume-Based Procurement for 41 Drugs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22901"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22901\/revisions"}],"predecessor-version":[{"id":22904,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/22901\/revisions\/22904"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}